Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology
Eugenio De Corso, Gianluca Bellocchi, Michele De Benedetto, et al.
Acta Otorhinolaryngologica Italica (2021) Vol. 42, Iss. 1, pp. 1-16
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 157
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment
Eugenio De Corso, Stefano Settimi, Claudio Montuori, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2684-2684
Open Access | Times Cited: 64
Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
Elena Cantone, Eugenio De Corso, Filippo Ricciardiello, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1215-1215
Open Access | Times Cited: 35
Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients
Giancarlo Ottaviano, Tommaso Saccardo, Giuseppe Roccuzzo, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1526-1526
Open Access | Times Cited: 35
Survey on Use of Local and Systemic Corticosteroids in the Management of Chronic Rhinosinusitis with Nasal Polyps: Identification of Unmet Clinical Needs
Eugenio De Corso, Carlotta Pipolo, Elena Cantone, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 897-897
Open Access | Times Cited: 32
Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement
Eugenio De Corso, Maria Beatrice Bilò, Andrea Matucci, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 846-846
Open Access | Times Cited: 30
How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review
Eugenio De Corso, Stefano Settimi, Claudio Montuori, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 2 (Suppl. 1), pp. S3-S13
Open Access | Times Cited: 17
Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach
Veronica Seccia, Maria D’Amato, Giulia Scioscia, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1096-1096
Open Access | Times Cited: 27
Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets
Junhu Tai, Mun Soo Han, Tae Hoon Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5523-5523
Open Access | Times Cited: 25
Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
Eugenio De Corso, Claudio Montuori, Stefano Settimi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 926-926
Open Access | Times Cited: 24
Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab
Giancarlo Ottaviano, Eugenio De Corso, Elena Cantone, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 234-234
Open Access | Times Cited: 14
Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
Antonella Loperfido, Andrea Ciofalo, Carlo Cavaliere, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 13
Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps
Eugenio De Corso, Silvia Baroni, Stefano Settimi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1251-1251
Open Access | Times Cited: 20
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
Giovanna Piazzetta, Nadia Lobello, Emanuela Chiarella, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 12
Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: A bicentric experience.
Gianluca Bellocchi, Antonella Loperfido, Francesco Maria Passàli, et al.
PubMed (2023) Vol. 94, Iss. 5, pp. e2023227-e2023227
Closed Access | Times Cited: 11
Raccomandazioni pratiche nella gestione ambulatoriale della rinosinusite cronica con poliposi nasale severa, nell’era dei biologici
Eugenio De Corso, Carlotta Pipolo, Elena Cantone, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 5, pp. 324-340
Open Access | Times Cited: 10
Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center
Reut Book, Shalom Eligal, Yuval Tal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3671-3671
Open Access | Times Cited: 10
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation
Matteo Trimarchi, Alessandro Vinciguerra, Andrea Rampi, et al.
Acta Otorhinolaryngologica Italica (2022) Vol. 42, Iss. 6, pp. 538-544
Open Access | Times Cited: 14
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis
Nicola Lombardo, Giovanna Piazzetta, Nadia Lobello, et al.
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 3-3
Open Access | Times Cited: 7
Therapeutical Targets in Allergic Inflammation
Lorenzo Salvati, Francesco Liotta, Francesco Annunziato, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2874-2874
Open Access | Times Cited: 11
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
Eugenio De Corso, Claudio Montuori, Silvia Baroni, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 5, pp. 2429-2440
Closed Access | Times Cited: 6
Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment
Sara Torretta, Eugenio De Corso, Nicolò Nava, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1734-1734
Open Access | Times Cited: 9
Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study
Marina Blanco–Aparicio, Javier Domínguez‐Ortega, Carolina Cisneros, et al.
Allergy Asthma and Clinical Immunology (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 5
A Practical Clinical Protocol for Monitoring Patients with Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyposis Treated with Biologics
Stefano Millarelli, Antonella Loperfido, Fulvio Mammarella, et al.
Allergy & Rhinology (2022) Vol. 13
Open Access | Times Cited: 8
Calprotectin in nasal secretion: a new biomarker of non-type 2 inflammation in CRSwNP
Eugenio De Corso, Silvia Baroni, Maria Elisabetta Onori, et al.
Acta Otorhinolaryngologica Italica (2022) Vol. 42, Iss. 4, pp. 355-363
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top